Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Turbine blood pumps.

G P Noon¹, D Morley, S Irwin

¹Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

Advances in Cardiac Surgery

|February 24, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

30-Day postoperative COVID-19 outcomes in 398 patients from regional hospitals utilising a designated COVID-19 minimal surgical site pathway.

Annals of the Royal College of Surgeons of England·2021

Same author

Angle grinder injuries in orthopedics: A case series and review of the literature.

Trauma case reports·2021

Same author

Correction to: Uncemented Thompson's hemiarthroplasty: safe, palliative and cost-effective surgery in the infirm patient-a consecutive series of 1445 cases.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2019

Same author

Interventions to Improve the Treatment of Malaria in an Acute Teaching Hospital in Ireland.

Irish medical journal·2018

Same author

Uncemented Thompson's hemiarthroplasty: safe, palliative and cost-effective surgery in the infirm patient-a consecutive series of 1445 cases.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2018

Same author

Taking culture seriously: Can we improve the developmental health and well-being of Australian Aboriginal children in out-of-home care?

Child: care, health and development·2017

Same journal

Single-stage complete unifocalization and repair for tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collateral arteries.

Advances in cardiac surgery·2001

Same journal

Videoscopic mitral valve repair and replacement using the port-access technique.

Advances in cardiac surgery·2001

Same journal

Aortic surgery in the Marfan syndrome.

Advances in cardiac surgery·2001

Same journal

Recent advances in reconstructive surgical management of hypoplastic left heart syndrome.

Advances in cardiac surgery·2001

Same journal

Pediatric interventional cardiology: the cardiologist's role and relationship with pediatric cardiothoracic surgery.

Advances in cardiac surgery·2001

Same journal

Optimal temperature for routine cardiopulmonary bypass.

Advances in cardiac surgery·2001

See all related articles

The MicroMed DeBakey VAD (Ventricular Assist Device) shows promising safety and performance in clinical trials for end-stage heart failure patients. This continuous-flow device offers advantages like smaller size and easier implantation, supporting patients awaiting heart transplants.

Area of Science:

Cardiology
Biomedical Engineering
Medical Devices

Background:

End-stage heart failure necessitates advanced circulatory support.
Traditional pulsatile ventricular assist devices (VADs) have limitations.

Purpose of the Study:

To evaluate the safety and performance of the MicroMed DeBakey VAD in a European clinical trial.
To assess the device's efficacy in providing circulatory support for patients with end-stage heart failure.

Main Methods:

Clinical trials involving implantation of the MicroMed DeBakey VAD.
Data collection on patient safety, device performance, and clinical outcomes.
Assessment of device advantages compared to pulsatile VADs.

Main Results:

Related Experiment Videos

The MicroMed DeBakey VAD demonstrated safety and adequate circulatory support in 44 European patients.
The device offers advantages including miniature size, ease of implantation, reduced bleeding, and low infection rates.
First demonstration of continuous blood flow compatibility with adequate tissue perfusion for up to 4.5 months.

Conclusions:

The MicroMed DeBakey VAD is safe and effective for supporting patients with end-stage heart failure.
The device can serve as a bridge to cardiac transplantation, potentially improving patient quality of life.
Continuous flow VAD technology shows compatibility with long-term circulatory support and tissue perfusion.